GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction

Is type D personality an independent risk factor for recurrent myocardial infarction or all-cause mortality in post-acute myocardial infarction patients?

(2017) Emelie Condén et al.   European Journal of Preventive Cardiology

Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria

(2016) Axel C Carlsson et al.   European Journal of Preventive Cardiology

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

(2015) Emil Hagström et al.   EUROPEAN HEART JOURNAL

Genome-wide DNA methylation study identifies genes associated with the cardiovascular biomarker GDF-15

(2015) Weronica E. Ek et al.   HUMAN MOLECULAR GENETICS

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   European Heart Journal-Cardiovascular Imaging

Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease

(2014) Pär Hedberg et al.   EUROPEAN JOURNAL OF HEART FAILURE

The inflammatory response in myocardial injury, repair and remodelling

(2014) Nikolaos G. Frangogiannis   Nature Reviews Cardiology

Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

(2014) Erika Assarsson et al.   PLoS One

Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community

(2013) Renate B. Schnabel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Targeting inflammatory pathways in myocardial infarction

(2013) Panagiota Christia et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients

(2013) Pavel Osmancik et al.   PLoS One

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men

(2013) Lars Wallentin et al.   PLoS One

Diagnosis and Management of Ischemic Heart Disease

(2013) Massimo Franchini et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate

(2012) Kunihiro Matsushita et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside

(2011) Xinye Xu et al.   BIOMARKERS

Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults

(2011) Lori B. Daniels et al.   CIRCULATION

New insights into apoptosis signaling by Apo2L/TRAIL

(2010) F Gonzalvez et al.   ONCOGENE

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

(2009) L. Lind et al.   EUROPEAN HEART JOURNAL

Acute myocardial infarction

(2008) Harvey D White et al.   LANCET

Expression, regulation and function of trail in atherosclerosis

(2007) Mary M. Kavurma et al.   BIOCHEMICAL PHARMACOLOGY